Physicians' Academy for Cardiovascular Education

Treatment benefit with PCSK9 antibody in patients with recent vs. remote MI

5' education - Feb. 2, 2020 - Baris Gencer, MD - Boston, MA, USA

Educational information

This video was recorded at the AHA in Philadelphia, USA, on November 17, 2019


Baris Gencer, MD works at Brigham and Women’s Hospital and is a research fellow of the TIMI Study Group.


This educational series is funded by an unrestricted educational grant provided by Amgen. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: